Nu Skin Enterprises (NUS) Competitors $8.24 -0.19 (-2.30%) As of 01:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NUS vs. COTY, HLF, USNA, NATR, MED, VERU, EL, IPAR, PBH, and HELEShould you be buying Nu Skin Enterprises stock or one of its competitors? The main competitors of Nu Skin Enterprises include Coty (COTY), Herbalife (HLF), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), MEDIFAST (MED), Veru (VERU), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), and Helen of Troy (HELE). Nu Skin Enterprises vs. Its Competitors Coty Herbalife USANA Health Sciences Nature's Sunshine Products MEDIFAST Veru Estee Lauder Companies Interparfums Prestige Consumer Healthcare Helen of Troy Nu Skin Enterprises (NYSE:NUS) and Coty (NYSE:COTY) are both consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk. Do analysts recommend NUS or COTY? Nu Skin Enterprises currently has a consensus target price of $6.88, indicating a potential downside of 16.53%. Coty has a consensus target price of $7.80, indicating a potential upside of 58.00%. Given Coty's stronger consensus rating and higher probable upside, analysts plainly believe Coty is more favorable than Nu Skin Enterprises.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Coty 2 Sell rating(s) 8 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.37 Which has more volatility and risk, NUS or COTY? Nu Skin Enterprises has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, Coty has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Is NUS or COTY more profitable? Nu Skin Enterprises has a net margin of -2.30% compared to Coty's net margin of -6.60%. Nu Skin Enterprises' return on equity of 6.99% beat Coty's return on equity.Company Net Margins Return on Equity Return on Assets Nu Skin Enterprises-2.30% 6.99% 3.25% Coty -6.60%5.61%1.87% Which has higher valuation and earnings, NUS or COTY? Coty has higher revenue and earnings than Nu Skin Enterprises. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Coty, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNu Skin Enterprises$1.73B0.23-$146.59M-$0.80-10.30Coty$6.12B0.70$89.40M-$0.48-10.28 Does the media prefer NUS or COTY? In the previous week, Coty had 1 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 2 mentions for Coty and 1 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 0.37 beat Coty's score of 0.37 indicating that Nu Skin Enterprises is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nu Skin Enterprises 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Coty 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of NUS or COTY? 82.8% of Nu Skin Enterprises shares are held by institutional investors. Comparatively, 42.4% of Coty shares are held by institutional investors. 2.0% of Nu Skin Enterprises shares are held by company insiders. Comparatively, 6.0% of Coty shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryCoty beats Nu Skin Enterprises on 11 of the 16 factors compared between the two stocks. Get Nu Skin Enterprises News Delivered to You Automatically Sign up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUS vs. The Competition Export to ExcelMetricNu Skin EnterprisesCOSMETICS&TLTRS IndustryStaples SectorNYSE ExchangeMarket Cap$407.63M$3.25B$16.07B$20.60BDividend Yield2.77%2.30%3.13%3.65%P/E Ratio-10.3127.7519.6727.20Price / Sales0.2321.1945.8653.52Price / Cash3.8517.4714.7222.28Price / Book0.633.766.034.58Net Income-$146.59M$37.65M$691.68M$995.22M7 Day Performance-11.91%-4.51%1.45%-1.09%1 Month Performance3.74%12.24%0.91%3.25%1 Year Performance-23.17%-20.00%3.64%6.97% Nu Skin Enterprises Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUSNu Skin Enterprises2.8156 of 5 stars$8.24-2.3%$6.88-16.5%-17.7%$407.63M$1.73B-10.313,100Positive NewsCOTYCoty4.3131 of 5 stars$4.97-2.4%$7.80+56.9%-51.9%$4.44B$6.12B21.2111,791HLFHerbalife4.252 of 5 stars$9.65-3.3%$11.50+19.2%-17.7%$1.02B$4.99B4.848,600USNAUSANA Health Sciences4.4864 of 5 stars$32.14-1.9%$36.00+12.0%-30.7%$610.28M$854.50M17.661,700Upcoming EarningsNATRNature's Sunshine Products2.0374 of 5 stars$16.02+2.8%$18.33+14.4%-5.1%$287.84M$454.36M26.42850Positive NewsHigh Trading VolumeMEDMEDIFAST3.6474 of 5 stars$14.62+0.3%$16.50+12.9%-26.3%$160.25M$602.46M11.57870VERUVeru2.8563 of 5 stars$0.58-3.8%$4.00+585.4%-39.0%$88.92M$16.89M0.00230Positive NewsELEstee Lauder Companies4.0557 of 5 stars$85.82-3.3%$74.45-13.2%-14.9%$31.92B$15.61B43.2862,000Trending NewsAnalyst ForecastIPARInterparfums4.2011 of 5 stars$136.05-1.8%$157.60+15.8%+5.0%$4.45B$1.45B26.59530News CoveragePositive NewsPBHPrestige Consumer Healthcare4.4002 of 5 stars$78.93-1.3%$93.33+18.2%+6.2%$3.95B$1.14B17.66540News CoveragePositive NewsHELEHelen of Troy2.8046 of 5 stars$30.10-7.8%$54.33+80.5%-67.3%$749.31M$1.91B5.171,883Earnings ReportInsider TradeGap Up Related Companies and Tools Related Companies Coty Competitors Herbalife Competitors USANA Health Sciences Competitors Nature's Sunshine Products Competitors MEDIFAST Competitors Veru Competitors Estee Lauder Companies Competitors Interparfums Competitors Prestige Consumer Healthcare Competitors Helen of Troy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NUS) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nu Skin Enterprises, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nu Skin Enterprises With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
